Zobrazeno 1 - 10
of 243
pro vyhledávání: '"E. Mattila"'
Autor:
L. A. Draper, F. J. Ryan, M. K. Smith, J. Jalanka, E. Mattila, P. A. Arkkila, R. P. Ross, R. Satokari, C. Hill
Publikováno v:
Microbiome, Vol 6, Iss 1, Pp 1-9 (2018)
Abstract Background Faecal microbiota transplantation (FMT) is used in the treatment of recurrent Clostridium difficile infection. Its success is typically attributed to the restoration of a diverse microbiota. Viruses (including bacteriophages) are
Externí odkaz:
https://doaj.org/article/367055b440d74585a3aa98db36442819
Autor:
Olivia Hölsä, Kaisa Teittinen, Anna Anttalainen, Liisa Ukkola-Vuoti, Milla Summanen, Kalle E Mattila
Publikováno v:
Therapeutic Advances in Urology, Vol 15 (2023)
Background: Novel receptor tyrosine kinase inhibitors and immune checkpoint inhibitors have been introduced to the treatment of advanced renal cell carcinoma (aRCC) during the past decade. However, the adoption of novel treatments into clinical pract
Externí odkaz:
https://doaj.org/article/f704f7eb566c4909b2111516953cd9ba
Publikováno v:
Bulletin of the Geological Society of Finland, Vol 58, Iss 1, Pp 109-129 (1986)
Geophysical analysis suggests the need for a revision of the eastern border of the early Proterozoic Northern Bothnian (or Kiiminki) schist belt. Recent geological field work has revealed places where the discordance and hiatus between Proterozoic an
Externí odkaz:
https://doaj.org/article/8c3854563184462988be609c8cffbfba
Autor:
Kalle E. Mattila, Teemu D. Laajala, Sara V. Tornberg, Tuomas P. Kilpeläinen, Paula Vainio, Otto Ettala, Peter J. Boström, Harry Nisen, Laura L. Elo, Panu M. Jaakkola
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract After surgery of localized renal cell carcinoma, over 20% of the patients will develop distant metastases. Our aim was to develop an easy-to-use prognostic model for predicting metastasis-free survival after radical or partial nephrectomy of
Externí odkaz:
https://doaj.org/article/f097036ba65447a59e243f07da006031
Autor:
Jitendra S Kanshana, Polly E Mattila, Michael C Ewing, Ashlee N Wood, Gabriele Schoiswohl, Anna C Meyer, Aneta Kowalski, Samantha L Rosenthal, Sebastien Gingras, Brett A Kaufman, Ray Lu, Daniel E Weeks, Stephen T McGarvey, Ryan L Minster, Nicola L Hawley, Erin E Kershaw
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0251895 (2021)
Obesity and diabetes have strong heritable components, yet the genetic contributions to these diseases remain largely unexplained. In humans, a missense variant in Creb3 regulatory factor (CREBRF) [rs373863828 (p.Arg457Gln); CREBRFR457Q] is strongly
Externí odkaz:
https://doaj.org/article/89877e3193b84a7a9605cc11de25289c
Autor:
Hannes Vihinen, Artturi Jokinen, Teemu D. Laajala, Nesna Wahid, Lotta Peltola, Tiia Kettunen, Aino Rönkä, Leena Tiainen, Tanja Skyttä, Laura Kohtamäki, Sanni Tulokas, Hanna Karhapää, Micaela Hernberg, Maria Silvoniemi, Kalle E. Mattila
Background: Antibiotic treatment may reduce the efficacy of cancer immunotherapy by disrupting gut microbiome. We aimed to study the association of antibiotics and survival outcomes in advanced cutaneous melanoma and non–small-cell lung cancer (NSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b9397807726ec00b5d416db90d48111
https://trepo.tuni.fi/handle/10024/149362
https://trepo.tuni.fi/handle/10024/149362
Autor:
Kalle E. Mattila, Siru Mäkelä, Soili Kytölä, Emma Andersson, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, Kristiina Aittomäki, Micaela Hernberg
Publikováno v:
Acta oncologica (Stockholm, Sweden). 61(10)
Detectable circulating tumor DNA (ctDNA) has been associated with worse prognosis in melanoma patients.We studied plasma ctDNA as a prognostic biomarker in 19 patients with metastatic melanoma and a detectable tumor mutation (13 BRAF, 5 NRAS, and 1 K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dde8bc1d26f46c50784d8f501709f2db
https://pubmed.ncbi.nlm.nih.gov/36307938
https://pubmed.ncbi.nlm.nih.gov/36307938
Publikováno v:
Cancers, Vol 14, Iss 239, p 239 (2022)
Approximately 20% of patients with renal cell carcinoma (RCC) present with primarily metastatic disease and over 30% of patients with localized RCC will develop distant metastases later, after complete resection of the primary tumor. Accurate postope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::23229eb671193277506c6dd06a365dc8
https://www.mdpi.com/2072-6694/14/1/239
https://www.mdpi.com/2072-6694/14/1/239
Publikováno v:
Cancers
Simple Summary Approximately one fifth of patients with newly diagnosed renal cell carcinoma (RCC) present with metastatic disease and over one third of the remaining patients with localized RCC will eventually have metastases spread to distant sites
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::adab796f8e7f08ada49d1c58adad6318
https://pubmed.ncbi.nlm.nih.gov/35008402
https://pubmed.ncbi.nlm.nih.gov/35008402
Autor:
Nicola L. Hawley, Ray Lu, Stephen T. McGarvey, Anna C. Meyer, Polly E. Mattila, Gabriele Schoiswohl, Michael Ewing, Sebastien Gingras, Erin E. Kershaw, Daniel E. Weeks, Ashlee N Wood, Aneta Kowalski, Brett A. Kaufman, Ryan L. Minster, Samantha L. Rosenthal, Jitendra S. Kanshana
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 9, p e0251895 (2021)
PLoS ONE, Vol 16, Iss 9, p e0251895 (2021)
Obesity and diabetes have strong heritable components, yet the genetic contributions to these diseases remain largely unexplained. In humans, a missense variant in Creb3 regulatory factor (CREBRF) [rs373863828 (p.Arg457Gln); CREBRFR457Q] is strongly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::903e3f3413f4aa8bf2b5a92c80c296a6
http://europepmc.org/articles/PMC8439463
http://europepmc.org/articles/PMC8439463